Anadrol 25mg Shield Pharma

Laboratory Research OverviewOxymetholone is a synthetic anabolic-androgenic steroid compound extensively studied for its potent effects on cellular protein synthesis mechanisms. This 25mg formulation from Shield Pharma provides researchers with a standardised reference material for investigating anabolic pathways in controlled laboratory environments. Scientists examining muscle tissue development and cellular growth responses frequently utilise this compound to study the intricate mechanisms underlying anabolic processes. Research facilities across the UK, including those accessible through steroidsshopuk.co.uk, rely on pharmaceutical-grade materials for consistent experimental outcomes.Research Applications and Study ProtocolsLaboratory investigations utilising oxymetholone focus on analysing its interaction with androgen receptors and subsequent cellular signalling cascades. Researchers studying comparative anabolic effects often examine this compound alongside materials from the oral steroids category to establish comprehensive datasets. In-vitro studies investigate protein synthesis acceleration, nitrogen retention mechanisms, and cellular metabolic adaptations under controlled conditions. Advanced research protocols examine the compound’s molecular binding affinity and receptor specificity, contributing valuable data to pharmaceutical development research. These investigations complement broader studies utilising compounds from the SARMs collection and peptide research materials for comparative analysis of anabolic mechanisms.Technical SpecificationsOxymetholone 25mg Research Compound SpecificationsParameterSpecificationActive CompoundOxymetholoneConcentration25mg per tabletManufacturerShield PharmaFormOral tabletsCAS Number434-07-1Molecular FormulaC21H32O3Molecular Weight332.48 g/molStorageRoom temperature, dry conditionsResearch Compliance and SafetyThis oxymetholone formulation is supplied exclusively for qualified research institutions conducting in-vitro laboratory studies. All research applications must comply with applicable regulations governing controlled substance research and maintain appropriate documentation for experimental protocols. This product is not intended for human consumption and must be handled by trained laboratory personnel following established safety procedures.